Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cyclokapron

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Current interest of orthopaedic surgeons in tranexamic acid (TXA) is rapidly increasing in the literature, and controversial… Expand
Is this relevant?
Review
2003
Review
2003
This article discusses evidence for the role of pharmacological interventions such as the protease inhibitor aprotinin (Trasylol… Expand
Is this relevant?
1999
1999
Objective To evaluate the effect of pre-operative administration of tranexamic acid in preventing prolonged post-operative… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
Is this relevant?
1994
1994
Plasminogen activator inhibitor-1 (PAI-1) deficiency causes a rare bleeding disorder by allowing excessive fibrinolysis to occur… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1991
Highly Cited
1991
A considerable number of agents have been proposed as causing ligneous conjunctivitis. We report the first case to arise as a… Expand
Is this relevant?
1975
1975
 
Is this relevant?
Highly Cited
1973
Highly Cited
1973
Abstract In a double-blind trial in patients with bleeding from the upper gastrointestinal tract, those whose source of bleeding… Expand
Is this relevant?
1973
1973
Two operations upon a giant gluteal lymph‐angioma in a boy were complicated by massive haemorrhage. The complication proved to be… Expand
Is this relevant?
Highly Cited
1972
Highly Cited
1972
In a double-blind trial tranexamic acid (AMCA, Cyclokapron), 1 g three times a day for five days, significantly reduced blood… Expand
Is this relevant?
Highly Cited
1970
Highly Cited
1970
In a double-blind trial tranexamic acid (Cyclokapron) 1 g. four times a day for the first four days of menstruation… Expand
Is this relevant?